Most Read Articles
4 days ago
Use of statin appears to reduce the risks of osteoporosis, hip fractures and vertebral fracture in patients newly diagnosed with a stroke, suggests a recent study.
07 Oct 2018
Patients using long-acting opioids with immunosuppressive properties are at greater risk of developing serious infections compared with those using the nonimmunosuppressive opioid counterpart, according to a study.
5 days ago
Monitoring of adverse events is lower in ambulatory patients on amiodarone than in those on dofetilide, a recent study has found. Improving the monitoring of such agents may help reduce the risk of morbidity in this population.
Yesterday
Rather than the presence or type or urinary incontinence, increasing severity of urinary incontinence correlates with increased depression, anxiety and stress among treatment-seeking women with lower urinary tract symptoms (LUTS), suggests a study.

Baricitinib may alter lipid profiles in rheumatoid arthritis patients

07 Mar 2018

Baricitinib treatment appears to be associated with increases in circulating lipid levels, including low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and triglyceride levels, but not in LDL-C:HDL-C ratio, according to a study.

Researchers analysed lipid data from phase II and III studies of oral baricitinib at 4-mg (n=997) and 2-mg (n=479) doses administered once daily in patients with moderate-to-severe active rheumatoid arthritis (RA). Additionally, they evaluated lipoprotein particle size and number and GlycA using nuclear magnetic resonance in one phase III study.

Pooled data revealed increased levels of total cholesterol, LDL-C, HDL-C and triglycerides following treatment with baricitinib. On the other hand, the drug did not significantly alter LDL-C:HDL-C ratio. Lipid levels plateaued by 12 weeks of treatment.

Nuclear magnetic resonance data showed that increases in HDL occurred across all particle sizes, whereas elevations in LDL were limited to larger particles, with small LDL particle levels decreasing. LDL increases were reversed in response to statin therapy.

The present data may reflect a positive impact on aspects of the lipid paradox observed in RA, researchers said.

Then again, additional studies investigating the effects of baricitinib on cholesterol and lipoprotein metabolism, as well as those evaluating cardiovascular event rates during long-term treatment, are warranted to further characterize the findings of the present study and their possible clinical implications, researchers added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Use of statin appears to reduce the risks of osteoporosis, hip fractures and vertebral fracture in patients newly diagnosed with a stroke, suggests a recent study.
07 Oct 2018
Patients using long-acting opioids with immunosuppressive properties are at greater risk of developing serious infections compared with those using the nonimmunosuppressive opioid counterpart, according to a study.
5 days ago
Monitoring of adverse events is lower in ambulatory patients on amiodarone than in those on dofetilide, a recent study has found. Improving the monitoring of such agents may help reduce the risk of morbidity in this population.
Yesterday
Rather than the presence or type or urinary incontinence, increasing severity of urinary incontinence correlates with increased depression, anxiety and stress among treatment-seeking women with lower urinary tract symptoms (LUTS), suggests a study.